Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Lee E, Burgess K (2025). Altern Ther Health Med.
Summary
A pilot safety study in two healthy adults who received BPC157 infusions, with cardiac, liver, kidney, thyroid and glucose markers measured at baseline and afterwards. The authors report no measurable effects on those markers and no adverse effects. The study did not assess efficacy, and the authors note the very small number of participants. No funding or conflicts were declared.